The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
Written by
in
Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Inflation Reduction Act of 2022, Kennedy, Robert F Jr, Law and Legislation, Medicare, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), Trump, Donald J, United States Politics and Government